Published: 13 February 2020
Author(s): Giacomo Buso, Adriano Alatri, Luca Calanca, Marco Fresa, Salah-Dine Qanadli, Raffaele Pesavento, Lucia Mazzolai
Section: Original article

Venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT), is a serious and potentially fatal disease, with an estimated annual incidence of 104–183 per 100,000 person-years in the general population [1]. Standard treatment for acute VTE is based on anticoagulation (AC). Nonetheless, when AC therapy is contraindicated, use of an inferior vena cava filter (IVCF) may be considered [2]. Several types of IVCF have been developed over time, including permanent and optional devices.

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness